Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Site search

38° Sunny
- Malvern, AR (72104)
  Today
  
  Sunny. Very warm. High 77F. Winds light and variable..
  
  Tonight
  
  Partly cloudy skies early will give way to cloudy skies late. Low 56F. Winds light and variable.
  
  Updated: February 9, 2026 @ 7:55 am
- Full Forecast

Home
- Contact Us
- Subscribe
News
- Local News
Sports
Obituaries
Photos
- Photo Galleries
- Videos
e-Edition
Classifieds
- Place an ad
Archives
Readers Choice 2025
Breast Cancer Quiz

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Femasys Inc. - Common Stock (NQ:FEMY)

0.5092 -0.0008 (-0.16%)

Streaming Delayed Price Updated: 9:41 AM EST, Feb 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Femasys Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update

March 28, 2024

Following FDA Clearance of FemaSeed®, Company Secures Capital to Support Commercial Initiatives; Cash Expected to Fund Operations Into 2H 2025

From Femasys Inc.

Via GlobeNewswire

Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape

March 21, 2024

-- CEO Kathy Lee-Sepsick and Chief Medical Officer James Liu to Join Jones Trading Analyst Catherine Novack in a Conversation on Current Treatment Options in Infertility Including FemaSeed® at 1PM ET...

From Femasys Inc.

Via GlobeNewswire

Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility

March 20, 2024

From Femasys Inc.

Via GlobeNewswire

Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024

March 13, 2024

From Femasys Inc.

Via GlobeNewswire

Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution

March 06, 2024

From Femasys Inc.

Via GlobeNewswire

Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF

February 28, 2024

From Femasys Inc.

Via GlobeNewswire

First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks ↗

February 21, 2024

Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of awareness. ARPA-H Sprint for Women's Health aims to promote innovative solutions.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 08, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 07, 2024

Via Benzinga

Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer

February 06, 2024

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women

January 26, 2024

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology

January 23, 2024

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at Stanford Medicine

December 15, 2023

From Femasys Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 14, 2023

Via Benzinga

Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer

November 30, 2023

-- Thought leader from top-ranked academic gynecology program to lead clinical and medical affairs at Femasys --

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launch

November 28, 2023

From Femasys Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 24, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 23, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 22, 2023

Via Benzinga

PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.

November 15, 2023

From PharmaCyte Biotech, Inc.

Via Business Wire

Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech

November 15, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2023 and Provides Corporate Update

November 14, 2023

From Femasys Inc.

Via GlobeNewswire

Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 31, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for...

Via Benzinga

Topics Intellectual Property

Femasys Inc. EU MDR Final Audit Successfully Completed

October 26, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. to Showcase FemBloc and its other Novel Products Advancing Women’s Health at the American Association of Gynecologic Laparoscopic Surgeons

October 25, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. Regains Compliance with Nasdaq Listing Requirements

October 11, 2023

From Femasys Inc.

Via GlobeNewswire

Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 09, 2023

Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 106% to $2.3901 after the company announced an Australian regulator approved first commercial drone flights in populated areas and near...

Via Benzinga

Why Avidity Biosciences Shares Are Trading Higher By Around 9%: 20 Stocks Moving Premarket ↗

October 09, 2023

Gainers Maris-Tech Ltd. (NASDAQ: MTEK) shares rose 38% to $1.38 in pre-market trading, after gaining 6% on Friday. Maris-Tech, on Friday, disclosed the launch of Jupiter Drones, an innovative,...

Via Benzinga

Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket ↗

October 05, 2023

Gainers

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Business
Local Events
Entertainment
Obituaries
Photos
Online Features

Services

Subscription Services
Submission Forms
Promote Your Event
Classifieds
Place an Ad
Email Alerts
Search
Weather

Malvern Daily Record

malvern-online.com
219 Locust Street
Malvern, AR 72104
Phone: 501-337-7523
Email: advertising@malvern-online.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Malvern, AR (72104)

Today

Tonight

Femasys Inc. - Common Stock (NQ:FEMY)

All News about Femasys Inc. - Common Stock

Sections

Services

Malvern Daily Record